1
|
Szymkuć S, Gajewska EP, Molga K, Wołos A, Roszak R, Beker W, Moskal M, Dittwald P, Grzybowski BA. Computer-generated "synthetic contingency" plans at times of logistics and supply problems: scenarios for hydroxychloroquine and remdesivir. Chem Sci 2020; 11:6736-6744. [PMID: 33033595 PMCID: PMC7500088 DOI: 10.1039/d0sc01799j] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2020] [Accepted: 06/02/2020] [Indexed: 01/21/2023] Open
Abstract
A computer program for retrosynthetic planning helps develop multiple "synthetic contingency" plans for hydroxychloroquine and also routes leading to remdesivir, both promising but yet unproven medications against COVID-19. These plans are designed to navigate, as much as possible, around known and patented routes and to commence from inexpensive and diverse starting materials, so as to ensure supply in case of anticipated market shortages of commonly used substrates. Looking beyond the current COVID-19 pandemic, development of similar contingency syntheses is advocated for other already-approved medications, in case such medications become urgently needed in mass quantities to face other public-health emergencies.
Collapse
Affiliation(s)
- Sara Szymkuć
- Institute of Organic Chemistry , Polish Academy of Sciences , ul. Kasprzaka 44/52 , Warsaw 02-224 , Poland .
| | - Ewa P Gajewska
- Institute of Organic Chemistry , Polish Academy of Sciences , ul. Kasprzaka 44/52 , Warsaw 02-224 , Poland .
| | - Karol Molga
- Institute of Organic Chemistry , Polish Academy of Sciences , ul. Kasprzaka 44/52 , Warsaw 02-224 , Poland .
| | - Agnieszka Wołos
- Institute of Organic Chemistry , Polish Academy of Sciences , ul. Kasprzaka 44/52 , Warsaw 02-224 , Poland .
| | - Rafał Roszak
- Institute of Organic Chemistry , Polish Academy of Sciences , ul. Kasprzaka 44/52 , Warsaw 02-224 , Poland .
| | - Wiktor Beker
- Institute of Organic Chemistry , Polish Academy of Sciences , ul. Kasprzaka 44/52 , Warsaw 02-224 , Poland .
| | - Martyna Moskal
- Institute of Organic Chemistry , Polish Academy of Sciences , ul. Kasprzaka 44/52 , Warsaw 02-224 , Poland .
| | - Piotr Dittwald
- Institute of Organic Chemistry , Polish Academy of Sciences , ul. Kasprzaka 44/52 , Warsaw 02-224 , Poland .
| | - Bartosz A Grzybowski
- Institute of Organic Chemistry , Polish Academy of Sciences , ul. Kasprzaka 44/52 , Warsaw 02-224 , Poland .
- IBS Center for Soft and Living Matter , 50, UNIST-gil, Eonyang-eup, Ulju-gun , Ulsan , 689-798 , South Korea
- Department of Chemistry , UNIST , 50, UNIST-gil, Eonyang-eup, Ulju-gun , Ulsan , 689-798 , South Korea
| |
Collapse
|
2
|
Lee SJ, Samala M, Woo SY, Hahn D, Kim D, Kadayat TM, Jung K, Kim J, Kim DS, Kwon S, Kim S, Kim KH, Nam SJ, Cho SJ, Chin J. Enantioselective Synthesis of a Novel Thiazoline Core as a Potent Peroxisome Proliferator-Activated Receptor δ Agonist. ACS OMEGA 2018; 3:1970-1976. [PMID: 30023820 PMCID: PMC6044852 DOI: 10.1021/acsomega.7b01689] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/01/2017] [Accepted: 01/29/2018] [Indexed: 06/08/2023]
Abstract
The convergent and enantioselective synthesis of a highly potent human peroxisome proliferator-activated receptor delta agonist is presented. More specifically, the thiazoline structure, which constitutes the biosynthetically distinctive core structure of pulicatin (a secondary metabolite of symbiotic bacteria), was synthesized from a commercially available and inexpensive chiral pool of l-threonine.
Collapse
Affiliation(s)
- Su-Jeong Lee
- New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, Republic
of Korea
| | - Mallesham Samala
- College
of Pharmacy, Kangwon National University, Chuncheon, Gangwon-do 24341, Republic of Korea
| | - Seo Yeon Woo
- New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, Republic
of Korea
| | - Dongyup Hahn
- School of Food Science and Biotechnology, and College of Pharmacy, Kyungpook National University, Daegu 41566, Republic
of Korea
| | - Dayoung Kim
- Department
of Chemistry and Nano Science, Global Top 5 Program, Ewha Womans University, Seoul 03760, Republic of Korea
| | - Tara Man Kadayat
- New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, Republic
of Korea
| | - Kyungjin Jung
- New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, Republic
of Korea
| | - Jina Kim
- New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, Republic
of Korea
| | - Dong-Su Kim
- New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, Republic
of Korea
| | - Sugyeong Kwon
- New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, Republic
of Korea
| | - Shinae Kim
- New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, Republic
of Korea
- School of Food Science and Biotechnology, and College of Pharmacy, Kyungpook National University, Daegu 41566, Republic
of Korea
| | - Kyung-Hee Kim
- New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, Republic
of Korea
| | - Sang-Jip Nam
- Department
of Chemistry and Nano Science, Global Top 5 Program, Ewha Womans University, Seoul 03760, Republic of Korea
| | - Sung Jin Cho
- New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, Republic
of Korea
| | - Jungwook Chin
- New
Drug Development Center, Daegu-Gyeongbuk
Medical Innovation Foundation, Daegu 41061, Republic
of Korea
| |
Collapse
|
3
|
Chekal B, Damon D, LaFrance D, Leeman K, Mojica C, Palm A, St. Pierre M, Sieser J, Sutherland K, Vaidyanathan R, Van Alsten J, Vanderplas B, Wager C, Weisenburger G, Withbroe G, Yu S. Development of the Commercial Route for the Manufacture of a 5-Lipoxygenase Inhibitor PF-04191834. Org Process Res Dev 2015. [DOI: 10.1021/op500412a] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Brian Chekal
- Chemical Research and Development, Pfizer Worldwide R&D-Groton Laboratories, 558 Eastern Point Road, Groton, Connecticut 06340, United States
| | - David Damon
- Chemical Research and Development, Pfizer Worldwide R&D-Groton Laboratories, 558 Eastern Point Road, Groton, Connecticut 06340, United States
| | - Danny LaFrance
- Chemical Research and Development, Pfizer Worldwide R&D-Groton Laboratories, 558 Eastern Point Road, Groton, Connecticut 06340, United States
| | - Kyle Leeman
- Chemical Research and Development, Pfizer Worldwide R&D-Groton Laboratories, 558 Eastern Point Road, Groton, Connecticut 06340, United States
| | - Carlos Mojica
- Chemical Research and Development, Pfizer Worldwide R&D-Groton Laboratories, 558 Eastern Point Road, Groton, Connecticut 06340, United States
| | - Andrew Palm
- Chemical Research and Development, Pfizer Worldwide R&D-Groton Laboratories, 558 Eastern Point Road, Groton, Connecticut 06340, United States
| | - Michael St. Pierre
- Chemical Research and Development, Pfizer Worldwide R&D-Groton Laboratories, 558 Eastern Point Road, Groton, Connecticut 06340, United States
| | - Janice Sieser
- Chemical Research and Development, Pfizer Worldwide R&D-Groton Laboratories, 558 Eastern Point Road, Groton, Connecticut 06340, United States
| | - Karen Sutherland
- Chemical Research and Development, Pfizer Worldwide R&D-Groton Laboratories, 558 Eastern Point Road, Groton, Connecticut 06340, United States
| | - Rajappa Vaidyanathan
- Chemical Research and Development, Pfizer Worldwide R&D-Groton Laboratories, 558 Eastern Point Road, Groton, Connecticut 06340, United States
| | - John Van Alsten
- Chemical Research and Development, Pfizer Worldwide R&D-Groton Laboratories, 558 Eastern Point Road, Groton, Connecticut 06340, United States
| | - Brian Vanderplas
- Chemical Research and Development, Pfizer Worldwide R&D-Groton Laboratories, 558 Eastern Point Road, Groton, Connecticut 06340, United States
| | - Carrie Wager
- Chemical Research and Development, Pfizer Worldwide R&D-Groton Laboratories, 558 Eastern Point Road, Groton, Connecticut 06340, United States
| | - Gerald Weisenburger
- Chemical Research and Development, Pfizer Worldwide R&D-Groton Laboratories, 558 Eastern Point Road, Groton, Connecticut 06340, United States
| | - Gregory Withbroe
- Chemical Research and Development, Pfizer Worldwide R&D-Groton Laboratories, 558 Eastern Point Road, Groton, Connecticut 06340, United States
| | - Shu Yu
- Chemical Research and Development, Pfizer Worldwide R&D-Groton Laboratories, 558 Eastern Point Road, Groton, Connecticut 06340, United States
| |
Collapse
|
4
|
Szekely G, Amores de Sousa MC, Gil M, Castelo Ferreira F, Heggie W. Genotoxic Impurities in Pharmaceutical Manufacturing: Sources, Regulations, and Mitigation. Chem Rev 2015; 115:8182-229. [DOI: 10.1021/cr300095f] [Citation(s) in RCA: 108] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Affiliation(s)
- Gyorgy Szekely
- School of Chemical Engineering & Analytical Science, The University of Manchester, The Mill, Sackville Street, Manchester M13 9PL, United Kingdom
| | - Miriam C. Amores de Sousa
- Department
of Bioengineering and Institute for Bioengineering and Biosciences
(iBB), Instituto Superior Técnico, Universidade de Lisboa, Avenida Rovisco Pais, 1049-001, Lisbon, Portugal
| | - Marco Gil
- Hovione FarmaCiencia SA, R&D, Sete Casas, 2674-506, Loures, Portugal
| | - Frederico Castelo Ferreira
- Department
of Bioengineering and Institute for Bioengineering and Biosciences
(iBB), Instituto Superior Técnico, Universidade de Lisboa, Avenida Rovisco Pais, 1049-001, Lisbon, Portugal
| | - William Heggie
- Hovione FarmaCiencia SA, R&D, Sete Casas, 2674-506, Loures, Portugal
| |
Collapse
|
5
|
Magano J, Dunetz JR. Large-Scale Carbonyl Reductions in the Pharmaceutical Industry. Org Process Res Dev 2012. [DOI: 10.1021/op2003826] [Citation(s) in RCA: 292] [Impact Index Per Article: 24.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Affiliation(s)
- Javier Magano
- Chemical Research and Development, Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States
| | - Joshua R. Dunetz
- Chemical Research and Development, Pharmaceutical Sciences, Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States
| |
Collapse
|
6
|
Organic solvent nanofiltration: A platform for removal of genotoxins from active pharmaceutical ingredients. J Memb Sci 2011. [DOI: 10.1016/j.memsci.2011.07.007] [Citation(s) in RCA: 116] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
|
7
|
Robinson DI. Control of Genotoxic Impurities in Active Pharmaceutical Ingredients: A Review and Perspective. Org Process Res Dev 2010. [DOI: 10.1021/op900341a] [Citation(s) in RCA: 94] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|